March 17, 2016
Allergan: FDA approves Vraylartm
Allergan’s Vraylartm (cariprazine), a once-daily oral atypical antipsychotic, is now available by prescription in pharmacies throughout the U.S. As Allergan…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Gary Sachs
September 17, 2015
FDA approves Vraylar for treatment of bipolar I disorder and schizophrenia
Allergan plc and Gedeon Richter Plc. have announced that the U.S. Food and Drug Administration (FDA) has approved Vraylartm (cariprazine) capsules,…